(NASDAQ: BPTS) Biophytis Sa's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Biophytis Sa's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast BPTS's revenue for 2024 to be $4,786,219,049, with the lowest BPTS revenue forecast at $4,786,219,049, and the highest BPTS revenue forecast at $4,786,219,049. On average, 1 Wall Street analysts forecast BPTS's revenue for 2025 to be $18,936,779,716, with the lowest BPTS revenue forecast at $18,936,779,716, and the highest BPTS revenue forecast at $18,936,779,716.
In 2026, BPTS is forecast to generate $36,416,884,070 in revenue, with the lowest revenue forecast at $36,416,884,070 and the highest revenue forecast at $36,416,884,070.